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MacrophageMicroRNAs (miRNAs) are small RNAs that play important regulatory roles in many cellular path-
ways. MiRNAs associate with members of the Argonaute protein family and bind to partially com-
plementary sequences on mRNAs and induce translational repression or mRNA decay. Using deep
sequencing and Northern blotting, we characterized miRNA expression in wild type and miR-155-
deﬁcient dendritic cells (DCs) and macrophages. Analysis of different stimuli (LPS, LDL, eLDL, oxLDL)
reveals a direct inﬂuence of miR-155 on the expression levels of other miRNAs. For example, miR-
455 is negatively regulated in miR-155-deﬁcient cells possibly due to inhibition of the transcription
factor C/EBPbeta by miR-155. Based on our comprehensive data sets, we propose a model of hierar-
chical miRNA expression dominated by miR-155 in DCs and macrophages.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MiRNAs are small 21 nucleotides (nt) long RNAs with important
functions in the regulation of gene expression [1,2]. MiRNAs are
single stranded RNA molecules that are derived from double
stranded precursor RNAs. In a step-wise process, the RNase III en-
zymes Drosha and Dicer cleave such miRNA precursors. Finally, the
mature miRNA is incorporated into the miRNA-induced silencing
complex (miRISC or miRNP) [3]. The opposing strand of the mature
miRNA in the precursor molecule is termedmiRNA⁄ and this RNA is
degraded during biogenesis. However, in some cases, both strands
can give rise to functional miRNAs. Since miRNA⁄ sequences can
originate from either the 50 or the 30 arm of the precursor and it
is very often not clear which strand the mature and the star se-
quence is, the nomenclature ‘miRNA-5p’ and ‘miRNA-3p’ is now
widely used. Within miRISC, miRNAs directly bind to a member
of the Argonaute (Ago) protein family and function as guides that
bring Ago proteins and the miRISC to partially complementary tar-
get sites on mRNAs [4]. After the recruitment of downstream fac-
tors, the target mRNA is translationally repressed and/or
degraded by exonucleases [5,6].
MiRNA-guided gene regulation has been implicated in literally
all cellular pathways. In addition, most cell types includingimmune cells such as macrophages or DCs contain speciﬁc miRNA
signatures that help to establish and maintain gene expression
programs. Consequently, these miRNA signatures change during
cell stimulation or differentiation and miRNAs in conjunction with
transcriptional regulation lead to alterations in global gene expres-
sion. Macrophages and DCs are not only essential for the immune
system but have also important functions during embryonic devel-
opment and are involved in a numerous diseases including meta-
bolic disease, atherosclerosis and cancer [7–9]. Both cell types
originate from myeloid progenitor cells in the bone marrow [10].
A common progenitor that can give rise to DCs and macrophages
is the monovyte. Monocytes are circulating white blood cells that
can differentiate into tissue-resident macrophages or DCs in steady
state and also in response to inﬂammation [11]. Among other
white blood cells, macrophages and DCs perform phagocytosis
and remove necrotic or apoptotic cells, pathogens or cell debris.
In addition, macrophages contain speciﬁc receptors allowing for
the uptake and clearance of different forms of low-density lipopro-
teins (LDL) such as oxidized LDL (oxLDL) or enzymatically hydro-
lyzed LDL (eLDL), which is frequently produced in plaques found
in atherosclerosis [12]. Opposed to macrophages, DCs have an
essential function for the initiation of adaptive immunity and upon
speciﬁc stimuli, e.g. contact to a pathogen, immature DCs mature
and migrate to the lymph nodes where they activate a T cell re-
sponse against the pathogen. In in vitro systems, DC maturation
is often achieved by lipopolysaccharide (LPS), a cell wall
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LDL. However, the physiological function of this effect remains
elusive.
MiRNAs play important roles in the hematopoietic system.
Many roles for miR-155 in the immune system have been reported.
MiR-155 knock out studies have shown that miR-155 is important
for T helper cell differentiation and thus an optimal T cell-depen-
dent antibody response [13]. In addition, it has been demonstrated
that miR-155 is also important for the function of B lymphocytes
and DCs [14]. Genome-wide miR-155 target identiﬁcation ap-
proaches identiﬁed regulated mRNAs important for B cell regula-
tion, lymphocyte homeostasis as well as cytokines, chemokines
and transcription factors [14,15]. MiR-155 function has also been
implicated in disease such as autoimmune inﬂammation [16] or
atherosclerosis [17]. In macrophages, miR-155 is up-regulated dur-
ing inﬂammatory response [18] and in DCs, miR-155 together with
miR-221 regulate cell development, apoptosis and interleukin-12
(IL-12) production. In addition to miR-155, many other miRNAs
play important roles in macrophage and DC biology [8,19,20]. For
example, miR-147 regulates inﬂammatory responses [21] and
miR-210 regulates the production of proinﬂammatory cytokines
in murine macrophages [22].
Although several proﬁling studies aiming at the identiﬁcation
of miRNAs that are involved in macrophage or DC functions
have been performed, the interplay between individual miRNAs
in such miRNA regulatory networks has not been investigated.
Using cloning and deep sequencing, we have characterized miR-
NA expression signatures in murine bone marrow-derived mac-
rophages and DCs stimulated or matured with LPS, LDL, oxLDL
and eLDL. We performed our experiments both in wt and in
miR-155 knock out cells allowing for the identiﬁcation of miR-
NAs that are miR-155-dependent. Our approach reveals that
miR-155 is a higher-ranking miRNA in macrophages and DCs
that rules the expression of several lower-ranking miRNAs. This
clear hierarchy leads to the establishment of miRNA signatures
that are speciﬁc for individual stimuli.
2. Materials and methods
2.1. Mouse strains/preparation of primary cells
Wildtype (C57BL/6) and mir-155/ [13], B6.Cg-
Mir155tm1.1Rsky/J, JAX) mice used in this study were bred and
maintained in a conventional animal facility according to local reg-
ulations, and sacriﬁced at 8–12 weeks of age for use in
experiments.
DCs were generated as described previously [23]. In brief,
ﬂushed bone marrow from femur and tibia was cultured in petri
dishes (Ø = 10 cm) and R10 culture medium (RPMI 1640 supple-
mented with 10% fetal calf serum, L-Glutamine and Penicillin/
Streptomycin, all from Life Sciences) supplemented with GM-CSF
hybridoma supernatant. At days 8–9 of culture, 5  10^5 DCs were
transferred to a cell culture dish (Ø = 6 cm) and matured by over-
night stimulation with either 200 ng/ml LPS (Sigma–Aldrich),
4 lg/ml LDL, oxLDL or eLDL. Macrophages were differentiated
according to the DC culture but using M-CSF hybridoma superna-
tant instead of GM-CSF [24]. At days 8–9 of macrophage culture,
conﬂuent petri dishes were stimulated such as the DCs. For each
condition, one sample was prepared for both deep sequencing
and validation by Northern blotting.
2.2. Data analysis
Obtained data was analyzed using an in house written script.
The data was mapped against miRBase 19 (August 2012) of mousemiRNAs (mus musculus). The minimal length of a read was set to 18
nucleotides, no mismatch was allowed. The reads for each miRNA
were normalized against the total read number of the respective
library.
For analysis of the libraries, a threshold was set to eliminate
very low abundant miRNAs. For all macrophage and all dendritic
cell libraries (10 libraries each), an average read number per mil-
lion of total reads was calculated for all miRNAs. The cutoff was
set to 5 reads per million of total reads for expression level analy-
ses and to 50 for fold change analyses. For scatterplots with expres-
sion data, all miRNAs above threshold were plotted. For
scatterplots on fold changes, again, all miRNAs above the cutoff
were plotted. Venn diagrams were created using a threshold of
twofold up and twofold down regulation, respectively.
2.3. Northern blot
Northern Blots were performed as described previously [25]. In
short, 5–10 lg of total RNA were separated on a 12% urea gel (Na-
tional Diagnostics). Ribooligonucleotides with a length of 19, 21
and 24 nt, that were labeled with c-32P-ATP prior to loading,
served as a size marker. After an ethidium bromide stain, the
RNA was blotted for 30 min at 20 V onto an Amersham Hybond-
N membrane (GE Healthcare). The RNA was crosslinked for 1 h to
the membrane using an EDC-solution [26] at 50 C. The membrane
was incubated with hybridization solution, a probe antisense to
the miRNA was added and it was incubated over night at 50 C.
After several washing steps, the membrane was exposed to a
screen and scanned with the PMI (Biorad).
2.4. Analysis of Col27a1 promoter region
Analysis of transcription factor binding sites was performed
using AliBaba2.1. 5 kb upstream of the transcription start site of
Col27a1 (NM_025685.3) and the intron sequence upstream of
miR-455 (NR_030477.1) were tested for binding sites of C/EBPbeta.
3. Results
3.1. MiRNA expression patterns in differentially matured DCs
Immature DCs mature upon contact with various stimuli. To
analyze whether different stimuli cause different miRNA expres-
sion responses in monocyte-derived murine DCs, we matured
DCs with LPS, oxLDL, eLDL and LDL (Fig. 1A). Small RNAs were
extracted, cloned and sequenced. While many miRNAs are ex-
pressed upon DC maturation independently of the speciﬁc mat-
uration agent several miRNAs appeared to be stimuli-speciﬁc
(Fig. 1B and C, Suppl. Tables 1 and 2). For example, 14 miRNAs
including miR-155 (both strands), miR-383-5p, miR-455 (both
strands), miR-9-3p or miR-149-5p were up-regulated under all
four conditions while miR-99b-3p, miR-143-3p, miR-181b-1-3p
and let-7e-5p were down-regulated (Fig. 1B and C, shown in
blue). Generally, the miRNA proﬁles obtained upon maturation
with LDL, oxLDL or eLDL overlap stronger compared to matura-
tion with LPS. Nevertheless, we identiﬁed also stimuli-speciﬁc
miRNAs (e.g. miR-19b-3p or miR-21a-3p for oxLDL, miR-29b-
3p or miR-101a-3p for eLDL and miR-15b-3p or miR-92b-3p
for LDL maturation (Fig. 1B and C)). LPS-maturation revealed
the largest set of speciﬁc miRNAs including miR-210-5p, miR-
96-5p, which are up-regulated (Fig. 1B) and miR-33-5p, miR-
148a-5p or miR-351-5p that are down-regulated (Fig. 1C). Taken
together, our comprehensive miRNA sequencing approach iden-
tiﬁes miRNA signatures that are speciﬁc to different stimuli
leading to DC maturation.
AB
eLDL
LDL
oxLDL
LPS
up-regulated miRNAs
14 miRNAs**
**miR-455-3p
miR-455-5p
miR-383-5p
miR-155-3p
miR-155-5p
miR-9-3p
miR-149-5p
miR-193b-3p
miR-132-3p
miR-677-5p
miR-5107-3p
miR-672-5p
miR-212-5p
miR-181c-5p
miR-187-3p
miR-181c-3p
miR-181d-5p
miR-101b-3p
miR-1948-3p
miR-674-3p
miR-127-3p
miR-29a-3p
miR-30c-2-3p
miR-760-3p
miR-5117-3p
miR-151-3p
miR-151-5p
miR-9-5p
miR-6539miR-210-5p   
miR-96-5p  
miR-146a-5p 
miR-182-5p
miR-147-3p
miR-183-5p 
miR-101c   
miR-674-5p    
miR-28a-5p     
miR-92b-3p      
miR-150-5p      
miR-19b-3p
miR-212-3p
miR-3470b
miR-29b-3p
miR-15b-3p
miR-676-3p
C
eLDL
LDL
oxLDL
LPS
miR-99b-3p
let-7e-5p
miR-181b-1-3p
miR-143-3p
miR-574-5p
miR-184-3p
miR-210-3p
miR-10b-5p
miR-181a-1-3p
miR-511-3p
miR-210-5p
miR-21a-5p
miR-125a-5p
miR-27a-5p
miR-342-5p
miR-99b-5p
miR-33-5p
miR-148a-5p
miR-351-5p
miR-700-3p
miR-34c-5p
miR-342-5p
miR-6539 
miR-92a-1-5p  
miR-365-2-5p   
miR-5114
miR-511-3p
miR-21a-3p
miR-101a-3p
miR-374b/c-5p
miR-190b-5p
miR-709
miR-92b-3p
down-regulated miRNAs
LPS oxLDL eLDL
LDL
miR-155 miR-155 miR-155
miR-155
Fig. 1. (A) MiRNA expression levels of wild type (wt) immature dendritic cells (DCs) are plotted against the miRNA expression levels of matured DCs (mDCs). Stimuli used
were LPS (top left), oxLDL (top middle), eLDL (top right) and LDL (bottom left). (B) Venn diagram showing up-regulated (>2-fold up) miRNAs in mDC maturation. (C) Venn
diagram showing down-regulated (>2-fold down) miRNAs in mDC maturation.
634 A. Dueck et al. / FEBS Letters 588 (2014) 632–6403.2. MiRNA expression patterns in differentially stimulated
macrophages
Not only DCs can be matured by LPS, LDL, oxLDL or eLDL but
also macrophages can be stimulated with these agents. To identifymiRNA regulatory networks in macrophages, we analyzed miRNA
expression in differentially stimulated murine bone marrow-de-
rived macrophages (Fig. 2). Macrophages were treated with LPS,
oxLDL, eLDL and LDL, small RNAs were isolated, cloned and ana-
lyzed by deep sequencing (Suppl. Table 1). Similar to DCs, several
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Fig. 2. (A) MiRNA expression levels of wild type (wt) unstimulated macrophages are plotted against the miRNA expression levels of stimulated macrophages. Stimuli used
were LPS (top left), oxLDL (top middle), eLDL (top right) and LDL (bottom left). (B) Venn diagram showing up-regulated (>2-fold up) miRNAs in stimulated macrophages. (C)
Venn diagram showing down-regulated (>2-fold down) miRNAs in stimulated macrophages.
A. Dueck et al. / FEBS Letters 588 (2014) 632–640 635miRNAs were differentially expressed (Fig. 2A). Interestingly, only
miR-155 was up-regulated and miR-3473b/e was down-regulated
under all four conditions (Fig. 2B and C, shown in blue). We also
identiﬁed miRNAs that are speciﬁcally regulated by the individual
stimuli in macrophages. For example, let-7f, g and c (all 5p strand)as well as miR-98-5p are up-regulated upon oxLDL stimulation,
let-7a and e (both-5p) are also up-regulated as observed for
LPS stimulation. Again, LPS stimulation had the strongest effect
on miRNA expression: miR-147-5p, miR-92b-3p, miR-129-5p
or miR-21a-3p were up- und miR-93-3p, miR-191-3p or
Table 1
miRNAs commonly regulated in macrophages and DCs.
LPS (up) LPS (down) oxLDL (up) oxLDL (down) eLDL (up) eLDL (down) LDL (up) LDL (down)
miR-155-5p miR-33-5p miR-155-5p no overlap miR-155-5p no overlap miR-155-5p no overlap
miR-210-5p miR-27a-5p miR-5117-5p miR-5117-5p
miR-147-3p miR-148a-5p miR-181d-5p
miR-101c miR-351-5p
miR-101b-3p miR-700-3p
miR-92b-3p miR-223-5p
miR-181a-1-3p
miR-92a-1-5p
636 A. Dueck et al. / FEBS Letters 588 (2014) 632–640miR-27a-5p were down-regulated. Similar to DCs, our comprehen-
sive sequencing analysis uncovered a number of stimuli-speciﬁc
miRNAs upon macrophage stimulation. Finally, we compared stim-
uli-speciﬁc miRNA regulation between DCs and macrophages to
identify miRNAs that are generally affected by the used stimuli.
Indeed, several miRNAs overlapped between DCs and macrophages
upon LPS, oxLDL and eLDL treatment (e.g. miR-155-5p, miR-
210-5p, miR-147-3p, miR-33-5p or miR-27a-5p; Table 1).A
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poietic system. We hypothesized that miR-155 not only affects
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A. Dueck et al. / FEBS Letters 588 (2014) 632–640 637deﬁcient mice (Fig. 3A, Suppl. Table 1). Wt cells and miR-155/
cells were analyzed separately and their fold changes between
immature cells and cells treated with the different stimuli were
plotted against each other to ﬁnd miR-155-dependent miRNAs
(Fig. 3). A threshold of 50 reads per million of total reads was cho-
sen to reduce low abundant and probably biologically irrelevant
miRNAs. In such plots, miR-155-independent miRNAs are found
between the two grey lines (indicating a 2-fold change), while
miR-155-dependent miRNAs are found as outliers (colored dots).
Several miRNAs were up- or down regulated in a miR-155-depen-
dent manner in LPS (Fig. 3A, upper left), oxLDL (upper right), eLDL
(lower left) or LDL (lower right) matured DCs. For example, miR-
10b-5p was mis-regulated in miR-155/ cells in all four different
stimuli. MiRNAs miR-184-3p and miR-187-3p were affected in
three out of four conditions.
We next analyzed miR-155-dependent miRNAs during macro-
phage stimulation (Fig. 3B). To identify miR-155-dependent miR-
NAs, we stimulated wt and miR-155/ macrophages with LPS,
LDL, oxLDL and eLDL, isolated small RNAs and analyzed them by
deep sequencing. Similar to DCs, we plotted the fold changes(stimulated vs. unstimulated) of all miRNAs found in miR-155/
cells against the fold changes of miRNAs found in wt macrophages
(Fig. 3B). Again, we found several miRNAs whose expression de-
pends on miR-155. MiR-709 was affected under all four conditions
and miR-223-5p was mis-regulated in two out of four conditions.
Again our data indicate that a miR-155-dependent miRNA network
exists in macrophages as well. Our sequencing data suggests that
several miRNAs might be affected by miR-155 during the matura-
tion of bone marrow-derived murine DCs and macrophages sug-
gesting a hierarchical system directed by miR-155.
3.4. Identiﬁcation of miR-155-dependent miRNAs in DCs and
macrophages by absolute expression levels
Comparing fold changes with each other might lead to a loss of
miRNAs that do not pass our ﬁlters but could nevertheless be sig-
niﬁcantly up or down regulated based on absolute expression lev-
els. Therefore, we compared expression levels between wt and
miR-155/ DCs (Fig. 4A, left) and macrophages (Fig. 4A, right)
with each other. Indeed, we identiﬁed several miRNAs that are
638 A. Dueck et al. / FEBS Letters 588 (2014) 632–640differentially expressed, among them are miR-455-3p, miR-143-3p
and miR-210-3p.
To consolidate our model of miR-155-dependent miRNA
expression, we validated the expression levels of several miRNAs
in DCs by Northern blotting (Fig. 4B). Analysis of miR-155 con-
ﬁrmed that the miR-155/ DCs are indeed miR-155 deﬁcient.
MiR-210-3p is down regulated upon all four stimuli in wt cells.
However, in miR-155 deﬁcient cells, miR-210-3p expression is sig-
niﬁcantly reduced indicating that miR-155 inﬂuences miR-210-3p
expression in DCs. Similar results were obtained for miR-143-3p.
Furthermore, miR-455-3p is expressed at rather low levels inCB
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3.5. MiR-155 targets C/EBPbeta leading to miR-455 regulation
In order to identify the molecular mechanisms underlying miR-
155-regulated miRNAs, we investigated miR-455-3p expression,
which is up-regulated in miR-155 deﬁcient cells (Fig. 4B). It has
been demonstrated before that miR-155 regulates the transcrip-
tion factor C/EBPbeta and affects adipocyte differentiation [27].
Therefore, we searched for putative C/EBPbeta binding sites close
to potential MiR-455 promoters (Fig. 5A). Indeed, three potential
sites are found in the MiR-455 containing intron of the Col27a1
gene. In addition, another four binding sites are present at the
Col27a1 promoter. Since miR-155 is induced the strongest in cells
stimulated with LPS, we next analyzed C/EBPbeta levels after LPS
maturation in wt and miR-155/ DCs (Fig. 5B). Upon LPS treat-
ment, C/EBPbeta is down-regulated, which is consistent with the
observed miR-155 increase. Strikingly, C/EBPbeta is stronglyA
miR-155
miR-709
miR-147-3p
Macrophages
miR-99b
miR-143-3p
miR-582-3p
host g
Exon1
Exo
10
predicted C/EBPbeta binding site
im
m
at
ur
e
+
LP
S
re
la
tiv
e 
C/
EB
Pb
et
a 
m
RN
A 
le
ve
l
wt DC miR-155-/- D
B
D
+
LP
0,0
0,5
1,0
1,5
2,0
2,5
3,0
3,5
4,0
4,5
+
o
xL
D
L
+
e
LD
L
+
LD
L
im
m
at
ur
e
+
LP
S
+
o
xL
D
L +e
LD
L
Fig. 5. (A) Schematic representation of the promoter region of the putative host gene of m
sites for the transcription factor C/EBPbeta are shown as blue boxes. (B) qPCR measurem
cells, both in wild type and in miR-155 deﬁcient cells. Levels were normalized to the 36B4
condition; light grey, matured cells. (C) Proposed regulatory model of miR-155 inﬂuence
represent supportive roles of miR-155 in expression levels, while dotted arrows represe
represent the inhibition by miR-155 in either expression level (solid line) or expression ch
in DCs.elevated in miR-155/ cells matured with LPS, which in turn
might lead to up regulation of miR-455-3p (Fig. 5B and C).
4. Discussion
MiRNAs are regulatory molecules that help to establish gene
expression proﬁles by regulating protein-coding genes. Such regu-
latory networks lead to the manifestation of cell identity. Thus,
miRNA expression proﬁles are speciﬁc to cell types and also the
target repertoire is often cell type-speciﬁc. Although very often
not well understood in molecular detail, the general effects of miR-
NAs on mRNA target expression are rather clear. In contrast, conse-
quences of miRNAs on the expression of other miRNAs have not
been analyzed. Here, we have characterized miRNA expression
proﬁles in wt DCs or macrophages and compared them with pro-
ﬁles frommiR-155/ DCs or macrophages. This approaches allows
for the establishment of a miRNA hierarchy directed by miR-155.
In macrophages, the expression of miR-99b-5p, miR-147-3p and
miR-143-3p is stimulated by miR-155, while miR-709 andmiR-155
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640 A. Dueck et al. / FEBS Letters 588 (2014) 632–640miR-582-3p are repressed (Fig. 5D). In DCs, miR-99b (both
strands), miR143-3p, miR-125a-5p, let-7e-5p, miR-10b-5p, miR-
210 (both strands) and miR143-3p are stimulated and miR-187-
3p, miR-676-3p, miR-383-5p, miR-455 (both strands), miR-672-
3p, miR-181c-3p, miR-181d-5p or miR-184-3p are repressed
(Fig. 5D).
How is such a regulation achieved? Most likely, either tran-
scriptional activators or repressors that bind to miRNA promoters
and regulate miRNA expression are directly targeted by miR-155
leading to stimulation or inhibition of expression. Supporting this
model, we ﬁnd that miR-455 contains several C/EBPbeta binding
sites at its putative promoter regions. Interestingly, C/EBPbeta is
a direct miR-155 target. However, miR-455 is mildly up regulated
upon maturation of wt DCs as well suggesting that additional path-
ways might contribute to overall miR-455 expression levels. Other
transcription factors that are miR-155 targets and could affect miR-
NA expression are Ship1 [28], Pu.1 [29] or Socs1 [30], for example.
In addition, it is also conceivable that regulatory proteins that
directly interact with miRNA processing intermediates could be
targeted by miR-155. Such regulatory factors are often cell-
type-speciﬁc. This might explain why we observe considerable
differences between miR-155-dependent miRNAs in DCs and mac-
rophages. A better understanding of the miR-155 target spectrum
will help elucidating how such a miRNA hierarchy is established
and maintained.
Recently, it has been shown that miR-709 regulates miR-15a
and miR-16 [31]. In this study, murine miR-709 seems to localize
to the nucleus where it directly binds to the pri-miR-15a/16 tran-
script and inhibits its expression. Although rather low abundant,
miR-709 is also among the miRNAs that are stimulated by miR-
155 in our study. However, in our system, we do not observe ef-
fects on miR-15a/16 suggesting again cell-type-speciﬁc effects.
Furthermore, miR-155 is not only important for macrophage or
DC function but also in many other cells of the hematopoietic sys-
tem such as CD8+ T cells [32] or T helper cells [13]. In addition,
miR-155 is important for brown fat tissue differentiation [27]
and has also been implicated in a number of different types of can-
cer [33]. It will be interesting to see whether miR-155 ruled miR-
NAs also exist in other tissues and what the consequences are for
cell function and disease.
5. Description of additional data ﬁles/data deposition
Supplementary Table 1 contains all miRNA deep sequencing
data obtained from DCs and macrophages. All sequencing data
were deposited at GEO database ID: GSE48404.
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